{"organizations": [], "uuid": "8f6dee6ebc51779e156776deeeb22a52e787f423", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-trevena-inc-and-jiangsu-nhwa-pharm/brief-trevena-inc-and-jiangsu-nhwa-pharmaceutical-announce-license-agreement-for-oliceridine-in-china-idUSFWN1S80MV", "country": "US", "domain_rank": 408, "title": "BRIEF-Trevena Inc And Jiangsu Nhwa Pharmaceutical Announce License Agreement For Oliceridine In China", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-05-02T00:01:00.000+03:00", "replies_count": 0, "uuid": "8f6dee6ebc51779e156776deeeb22a52e787f423"}, "author": "", "url": "https://www.reuters.com/article/brief-trevena-inc-and-jiangsu-nhwa-pharm/brief-trevena-inc-and-jiangsu-nhwa-pharmaceutical-announce-license-agreement-for-oliceridine-in-china-idUSFWN1S80MV", "ord_in_thread": 0, "title": "BRIEF-Trevena Inc And Jiangsu Nhwa Pharmaceutical Announce License Agreement For Oliceridine In China", "locations": [], "entities": {"persons": [{"name": "ann", "sentiment": "negative"}, {"name": "trevena", "sentiment": "none"}], "locations": [{"name": "china", "sentiment": "none"}, {"name": "jiangsu", "sentiment": "none"}], "organizations": [{"name": "brief-trevena inc", "sentiment": "negative"}, {"name": "nhwa", "sentiment": "none"}, {"name": "trevena inc", "sentiment": "none"}, {"name": "oliceridine in china reuters staff", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "jiangsu nhwa pharmaceutical co ltd", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 1 (Reuters) - Jiangsu Nhwa Pharmaceutical Co Ltd :\n* TREVENA INC. AND JIANGSU NHWA PHARMACEUTICAL CO. LTD ANNOUNCE LICENSE AGREEMENT FOR OLICERIDINE IN CHINA\n* TREVENA INC - TREVENA TO RECEIVE UPFRONT AND MILESTONE PAYMENTS AND ROYALTIES\n* TREVENA INC - NHWA GRANTED A LICENSE TO DEVELOP, MANUFACTURE, AND COMMERCIALIZE OLICERIDINE IN CHINA\n* TREVENA INC - TREVENA EXPECTS TO RECEIVE NEAR-TERM PAYMENTS OF $5.5 MILLION Source text for Eikon: Further company coverage:\n ", "external_links": [], "published": "2018-05-02T00:01:00.000+03:00", "crawled": "2018-05-02T00:14:26.014+03:00", "highlightTitle": ""}